大鼠鼻粘膜肽能神经末梢分布的研究

用免疫组化技术（ＡＢＣ法）系统研究了大鼠鼻粘膜９种肽能神经末梢分布的特征,这９种神经肽分别是Ｐ物质（ｓｕｂｓｔａｎｃｅＰ,ＳＰ）,神经激肽Ａ（ｎｅｕｒｏｋｉｎｉｎＡ,ＮＫＡ）,神经激肽Ｂ（ｎｅｕｒｏｋｉｎｉｎＢ,ＮＫＢ）,降钙素基因相关肽（ｃａｌｃｉｔｏｎｉｎｇｅｎｅ－ｒｅｌａｔｅｄｐｅｐｔｉｄｅ,ＣＧＲＰ）,血管活性肠多肽（ｖａｓｏａｃｔｉｖｅｉｎｔｅｓｔｉｎａｌｐｏｌｙｐｅｐｔｉｄｅ,ＶＩＰ）,神经肽Ｙ（ｎｅｕｒｏｐｅｐｔｉｄｅＹ,ＮＰＹ）,甘丙肽（ｇａｌａｎｉｎ,ＧＡＬ）,生长抑素（ｓｏｍａｔｏｓｔａｔｉｎ,ＳＯＭ）及神经降压素（ｎｅｕｒｏｔｅｎｓｉｎ,ＮＴ）,同时选择与鼻粘膜神经肽（ＮＰ）作用密切相关的三叉神经节（ＴＧ）细胞进行上述ＮＰ的定位。用重组ＰＳＰ６５质粒（４００ＳＯＭｃＤＮＡ）制备ＳＯＭｍＲＮＡ单链探针,以地高辛精标记,在鼻粘膜及ＴＧ细胞进行ＳＯＭｍＲＮＡ的原位杂交组化研究。结果提示大鼠鼻粘膜有丰富的肽能神经末梢;ＴＧ细胞含有多种ＮＰ并且可以合成ＳＯＭ。该研究结果对重新认识鼻粘膜神经分布规律有一定意义。     

垂体催乳素瘤的病因及发病机制的实验研究

应用在同一只雄性ＳＤ大鼠中,保留原位垂体并在肾囊内植入一异体垂体,同时背部埋植装有１７－β－雌二醇（１７－β－ｅｓｔｒａｄｉｏｌ,Ｅ２）的药泵,经Ｅ２在体作用６０￣１２０天后,其原位垂体和异体移植入肾囊的垂体同时形成２垂体催乳素（ｐｒｏｌａｃｔｉｎ,ＰＲＬ）瘤的动物模型,研究ＰＲＬ瘤的发病机制。结果表明,Ｅ２长期作用可诱发原位垂体和远离下丘脑的移植垂体同时形成ＰＲＬ瘤,并伴高ＰＲＬ血症和ＰＲＬ基因     

VIP对气道平滑肌增殖的调节作用

为探讨血管活性肠肽（ＶＩＰ）对气道平滑肌增殖的影响及机制,我们以体外培养的犬气管平滑肌细胞为对象,以３Ｈ－ＴｄＲ掺入为指标,探讨了ＶＩＰ的作用,并分析了ＶＩＰ受体拮抗剂［４Ｃｌ－Ｄ－Ｐｈｅ６,Ｌｅｕ１７］ＶＩＰ,腺苷酸环化酶激活剂Ｆｏｒｓｋｏｌｉｎ,百日咳杆菌毒素（ＰＴｘ）和磷酯酶Ｃ抑制剂新霉素等对ＶＩＰ作用的影响。实验发现：ＶＩＰ对犬气道平滑肌细胞体外增殖有显著的抑制作用,且呈剂量依赖性。［４Ｃｌ－Ｄ－Ｐｈｅ６,Ｌｅｕ１７］－ＶＩＰ能完全阻断ＶＩＰ的作用,Ｆｏｒｓｋｏｌｉｎ则呈现出对ＶＩＰ的促进效应,ＰＴｘ和新霉素对ＶＩＰ作用无任何影响。上述结果提示：ＶＩＰ通过特异性受体在ＰＴｘ非敏感型Ｇ－蛋白介导下,激活ＡＣ,使平滑肌细胞内ｃＡＭＰ浓度增加,而发挥平滑肌细胞增生抑制效应     

人肾上腺内肽能神经的超微结构

应用抗生蛋白链菌素一生物素一过氧化物酶复合物的免疫电镜技术,在相邻切片中,分别观察人肾上腺内ＮＰＹ、ＶＩＰ、ＳＰ和ＣＧＲＰ免疫反应神经纤维的超微结构和免疫反应物的定位。ＮＰＹ和ＶＩＰ免疫反应物位于小颗粒羹泡和线粒体外膜,部分嗜铬细胞呈ＮＰＹ免疫反应阳性。ＳＰ和ＣＧＲＰ免疫反应物主要定位于大颗粒囊泡内。ＳＰ和ＣＧＲＰ免疫反应轴突与嗜铬细胞形成对称性或非对称性的轴体突轴。测量了这４种肽能神经末梢的直径,从而推测其来源,并讨论了该４种神经肽对人肾上腺的作用。     

大鼠催乳素基因真核细胞可表达性质粒的构建及应用研究

７３５ｂｐ的ＰＲＬｃＤＮＡ片段从质粒ＰＲＬ－ＳＰ６５＃１中回收后,用粘性末端连接法将其重组到真核表达载体ｐｃＤＮＡ３上,筛选出正向连接重组体ｐｃＤＮＡ３－ＰＲＬＳ和反向连接重组体ｐｃＤＮＡ３－ＰＲＬＡＳ。将重组体ｐｃＤＮＡ３－ＰＲＬｓ和空载体ｐｃＤＮＡ３分别转入ＮＩＨ３Ｔ３细胞系,用Ｇ４１８筛选出阳性细胞后与未转染的ＮＩＨ３Ｔ３细胞在加Ｅ２和不加Ｅ２的情况下,用原位杂交的方法,分别用ＰＲＬｃＤＮＡ探针和原癌基因ｃ－Ｈ－ｒａｓｃＤＮＡ探针进行检测,未转染的ＮＩＨ３Ｔ３细胞在加Ｅ２和不加Ｅ２时都几乎无催乳素基因的表达,同样,转入空载体的ＮＩＨ３Ｔ３细胞也无ＰＲＬ的表达,而转入重组体ｐｃＤＮＡ３－ＰＲＬＳ的ＮＩＨ３Ｔ３细胞则有大量的ＰＲＬ基因的表达,与对照组相比有显著差异（Ｐ＜０．０１）。正常和转入空载体的ＮＩＨ３Ｔ３细胞有一定程度的原癌基因ｃ－Ｈ－ｒａｓ的表达,当分别加入Ｅ２和转入重组体ｐｃＤＮＡ３－ＰＲＬＳ后,ＮＩＨ３Ｔ３细胞中的ｃ－Ｈ－ｒａｓ基因表达水平都显著升高（Ｐ＜０．０５）。     

海马培养细胞的缺氧损伤及降钙素基因相关肽的保护作用

采用新生大鼠海马细胞进行分离培养,观察缺氧对海马培养细胞的影响以及降钙素基因相关肽（ＣＧＲＰ）的保护作用。结果表明：培养１２ｄ的细胞置于缺氧环境（９５％Ｎ２＋５％ＣＯ２）中４─２４ｈ后,随着缺氧时间延长,神经细胞由肿胀、胞膜受损乃至死亡,台盼蓝染色细胞数增多,乳酸脱氢酶（ＬＤＨ）和Ｋ＋漏出增加。经ＣＧＲＰ孵育的细胞缺氧后形态变化轻微,细胞死亡率以及ＬＤＨ和Ｋ＋漏出量均明显低于对照组。本结果表明,体外培养的海马神经元对缺氧甚为敏感。缺氧造成海马细胞严重损伤,ＣＧＲＰ对此有明显的保护作用。     

气道上皮细胞的抗氧化损伤保护及微环境调控

本工作建立了臭氧对原代培养的兔支气管上皮细胞（ＢＥＣ）损伤模型,观察到血管活性肠肽（ＶＩＰ）、表皮生长因子（ＥＧＦ）、热应激等微环境理化因子可减轻细胞损伤,具有细胞保护作用,其保护机制与提高还原谷胱甘肽（ＧＳＨ）含量有关,并依赖于蛋白激酶的磷酸化调节及基因转录。ＢＥＣ细胞在基础情况下有ｂｃｌ－２基因的低水平表达。ＶＩＰ和ＥＧＦ可促进ｂｃｌ－２基因转录,增强ＢＥＣ的抗氧化损伤能力。ＥＧＦ或热应激促进     

血管活性肠肽免疫阳性神经元在家鸽中脑和间脑中的分布

用免疫细胞化学技术研究了血管活性肠肽（ＶＩＰ）阳性神经元在家鸽（Ｃｏｌｕｍｂａｌｉｖｉａ）中脑和间脑核团的分布。实验结果表明,ＶＩＰ阳性神经元主要分布于如下核团：下丘侧核（ＬＨＹ）、蔡氏腹区（ＡＶＴ）、中央灰质（ＧＣｔ）、中脑深核腹部（ＭＰｖ）、中脑外侧核背部（ＭＬｄ）、脑桥脚盖致密体（ＴＰｃ）、丘脑间核（ＩＣｏ）、兰斑核（ＬｏＣ）、脑桥嘴部网状核（ＲＰＯ）、兰斑背部亚核（ＳＣｄ）、兰斑腹部亚核（ＳＣｖ）和脑桥尾部网状核巨细胞部（ＲＰｇｃ）。在这些核团中,除ＭＬｄ中的ＶＩＰ阳性神经元位于其背部外,其余核团中ＶＩＰ阳性神经元分布基本上是均匀的。     

迷走背核复合体微量注射血管活性肠肽刺激大鼠胃酸分泌

本工作采用Ｇｈｏｓｈ－Ｓｃｈｉｌｄ法收集大鼠胃酸,观察了小脑延髓池、迷走背核复合体和脊髓蛛网膜下腔微量注射血管活性肠肽对胃酸分泌的影响,并初步分析其机制。结果表明：（１）小脑延髓池注射ＶＩＰ（１０μｇ）ｓ可强烈地刺激胃酸分泌,高峰期在注射后６０至８０ｍｉｎ,持续时间超过２．５ｈ。（２）双侧膈下迷走神经切断可完全阻断小脑延髓池微量注射ＶＩＰ刺激胃酸分泌的效应,（３）迷走背核复合体微量注射ＶＩＰ（１μ     

电场刺激对离体温育垂体前叶促肾上腺皮质激素分泌的影响

本实验应用离体温育大鼠垂体前叶组织块结合电场刺激及放射免疫测定方法,观察了垂体前叶内的神经纤维兴奋对促肾上腺皮质激素（ＡＣＴＨ）分泌的影响以及其它因素的作用。结果表明,一定参数的电场刺激使温育的大鼠四分之一垂体前叶组织块ＡＣＴＨ分泌增加,能被河豚毒素（ＴＴＸ）和藜芦碱部分阻断,此效应也可被地塞米松显著抑制,而同一参数的电场刺激与促肾上腺皮质激素释放激素（ＣＲＨ）诱发的ＡＣＴＨ分泌没有相互作用。经典神经递质受体阻断剂阿托品、心得安、酚妥拉明对电场刺激诱发的ＡＣＴＨ分泌没有显著影响;ＧＡＥＡ＿Ａ受体拮抗剂荷包牡丹碱明显促进此效应。该作用不受Ｐ物质拮抗剂ｓｐａｎｔｉｄｅ的影响,而降钙素基因相关肽（ＣＧＲＰ）受体拮抗剂ＣＧＲＰ片段８－３７能部分阻断这一作用。上述结果提示电场刺激所诱发的ＡＣＴＨ分泌可能部分由垂体前叶内ＣＧＲＰ能神经纤维介导。     

Phosphatase of Regenerating Liver 2 (PRL2) Is Essential for Placental Development by Down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and Activating Akt Protein

The PRL (phosphatase of regenerating liver) phosphatases are implicated in the control of cell proliferation and invasion. Aberrant PRL expression is associated with progression and metastasis of multiple cancers. However, the specific in vivo function of the PRLs remains elusive. Here we show that deletion of PRL2, the most ubiquitously expressed PRL family member, leads to impaired placental development and retarded growth at both embryonic and adult stages. Ablation of PRL2 inactivates Akt and blocks glycogen cell proliferation, resulting in reduced spongiotrophoblast and decidual layers in the placenta. These structural defects cause placental hypotrophy and insufficiency, leading to fetal growth retardation. We demonstrate that the tumor suppressor PTEN is elevated in PRL2-deficient placenta. Biochemical analyses indicate that PRL2 promotes Akt activation by down-regulating PTEN through the proteasome pathway. This study provides the first evidence that PRL2 is required for extra-embryonic development and associates the oncogenic properties of PRL2 with its ability to negatively regulate PTEN, thereby activating the PI3K-Akt pathway.     

疏肝健脾法对产后缺乳大鼠催乳素及其受体表达的影响研究

目的:观察疏肝健脾法对产后缺乳肝郁脾虚证大鼠乳腺组织形态学与催乳素(prolactin,PRL)及其受体(prolactin receptor,PRLR)表达的影响。方法:采用甲磺酸溴隐亭溶液+慢性束缚法复制大鼠产后缺乳肝郁脾虚病证结合动物模型,随机分为模型组、空白对照组、西药对照组、中药低、中、高剂量组,每组8只,共6组。药物干预后,采用HE染色及免疫组化法比较不同干预方法对产后缺乳大鼠乳腺组织形态与催乳素及其受体表达的影响,匀浆乳腺组织,采用ELISA法检测乳腺组织催乳素(PRL)、血清催乳素(PRL)、胃泌素(GAS)、血清下丘脑一垂体一肾上腺轴(The hypothalamic-pituitary-adrenal axis,HPA轴)水平变化:促肾上腺皮质激素释放激素(CRH)、促肾上腺皮质激素(ACTH)、皮质醇(COR)。结果:与模型组相比,西药对照组和中药低、中、高剂量组均可促进乳腺组织向泌乳活跃期发育,表现为腺泡腔充盈、腺泡上皮细胞数量增多、结缔组织和脂肪组织退化,同时增加乳腺组织中PRL(空白对照组(145.72±16.332)、中药中剂量组(127.39±10.854)西药对照组(80.79±18.112)、中药低剂量组(89.42±14.183)、中药高剂量组(88.02±12.064)模型组(54.32±7.128))(P0.05)及PRLR(空白对照组(139.76±14.199)、中药中剂量组(129.09±18.755)西药对照组(87.42±8.390)、中药低剂量组(81.54±11.090)、中药高剂量组(85.167±9.494)模型组(60.93±11.767))的表达(P0.05)。与模型组相比,疏肝健脾中药可降低过高的血清CRH、ACTH、COR水平,升高乳腺组织PRL、血清GAS及PRL水平(P0.05)。其中,中药中剂量组疗效优于其他用药各组(P0.05)。结论:疏肝健脾法促进产后缺乳大鼠的泌乳作用机制与增加PRL及其受体表达、调节胃肠功能、抑制HPA轴的亢进状态,从而促进乳腺组织形态向泌乳活跃期发育密切相关。     

人参茎叶皂甙对大鼠垂体催乳素分泌的影响及其机制的探讨

本实验观察了人参茎叶皂甙(GSLS)对雄性大鼠血浆催乳素水平、垂体催乳素细胞超微结构和下丘脑中枢神经递质的影响。结果表明:5～100mg/kg的GSLS可刺激催乳素的释放,剂量加大反而无效;GSLS还可拮抗急性饥饿所致的大鼠垂体催乳素细胞超微结构的损伤;GSLS能分别使大鼠下丘脑中多巴胺和5-羟色胺含量增高和降低。结果表明,GSLS有刺激垂体催乳素分泌的作用,其机制可能与其直接作用于垂体细胞和/或经下丘脑中多巴胺和5-羟色胺含量的变化有关。     

Effects of human chorionic gonadotropin combined with clomiphene on Serum E2, FSH,LH and PRL levels in patients with polycystic ovarian syndrome

ObjectiveEffects of human chorionic gonadotropin combined with clomiphene on serum E₂, FSH, LH and PRL levels in patients with polycystic ovarian syndrome were analyzed.Methods90 patients with polycystic ovarian syndrome treated from January 2015 to March 2016 were randomly and evenly divided into control group and observation group. Patients in the control group were only treated with clomiphene. On the basis of the treatment in control group, human chorionic gonadotropin was added in the treatment of observation group. The changes of E₂, FSH, LH, PRL levels were compared between two groups before and after the treatment. Clinical curative effects of patients in the two groups was evaluated. Adverse reactions during treatment in two groups were observed and recorded. The incidence of adverse reactions was calculated.ResultsSerum E₂, FSH, LH and PRL levels in the two groups decreased significantly after treatment compared with that before treatment. The difference is statistical significant (P < 0.05). After the treatment, E₂, FSH, LH and PRL levels in the observation group were lower than that in the control group and the difference is statistical significant (P < 0.05). Total effective rate was 64.44% in the control group and 93.33% in the observation group. There were statistically significant difference in clinical curative effects in the two groups (P < 0.05). Different degrees of adverse reactions were found in both groups during treatment, such as nausea, vomiting, anorexia, liver dysfunction. There were 2 cases of nausea, 2 cases of vomiting, 3 cases of anorexia and 1 case of liver dysfunction from the 45 patients in control group. The total incidence of adverse reactions was 17.78% (8/45). There were 1 case of nausea, 1 case of vomiting, 1 case of anorexia and no liver dysfunction from the 45 patients in observation group. The total incidence of adverse reactions was 6.67% (3/45). The total incidence of adverse reactions in the observation group was significantly higher than that in the control group and the difference was not statistically significant (P > 0.05).ConclusionCombined use of human chorionic gonadotropin can significantly reduce serum E₂, FSH, LH and PRL levels, improve clinical curative effects and reduce the incidence of adverse reactions. Human chorionic gonadotropin has high application value on the treatment of polycystic ovary syndrome.     

A novel polymorphism of the porcine prolactin gene (PRL)

Prolactin is a protein hormone playing a role in the maintenance of pregnancy in the pig by action on corpora lutea cells and possibly initiating production of progesterone. The prolactin gene is 10 kb in size and is composed of 5 exons and 4 introns. The present work is a report of the swine PRL gene--comparative DNA sequence analysis and the SNP revealed in the promoter region. Based on the bovine prolactin gene, three primer pairs were designed using the Primer3 on-line software. The overlapping fragments covered about 400 nucleotides of the promoter and 78 nucleotides of exon 1. The fragments were amplified; two of them were sequenced and deposited in the GenBank database (AY341908 and AY905690). All fragments were analyzed using multitemperature SSCP (MSSCP) technique. Only one fragment appeared to show a different MSSCP pattern. The samples of differing MSSCP conformers were sequenced and the C499T transition was identified in the 5'UTR region of the gene. The HphI restriction enzyme appeared to recognize the novel SNP. The alignment for homology analysis was performed with porcine, bovine (X01452) and human (NM_000948) DNA sequences available in GenBank database, using BLAST software. The comparative homology analysis results varied in dependence on the species and functional region of the gene.     

A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice

The heterozygous prolactin (PRL) receptor (PRLR +/-) mouse fails to develop a fully functional mammary gland at the end of the first pregnancy and shows markedly impaired lobuloalveolar development and milk secretion in young females. The PRLR is expressed ubiquitously, with various proportions of long and short isoforms in different tissues. Conflicting data have appeared on the putative role of the receptor short forms, with both agonist and antagonistic actions proposed. To assess whether the mouse PR-1 short isoform of the PRLR is potentially able to transduce a signal, we overexpressed it in heterozygous mice and investigated its effect on the rescue of mammary development. PRLR+/- mice were not able to develop a functional mammary gland, but restoration of mammary alveolar development and an increase in the expressions of casein and whey acidic protein genes were observed in transgenic PRLR+/- mice expressing the short form of the PRLR, leading to a complete rescue of mammary gland development and function in young females. These results demonstrate that PR-1, the short form of the PRLR, can improve mammary development in PRLR+/- mice, which compensates for the haploinsufficiency of the receptor long form; this effect is probably caused by accelerated proliferation and an activation of the PRLR signaling cascade, resulting in activation of target genes involved in mammary development and milk synthesis.     

THE CHROMOSOMES OF THE SEMPERVIVOIDEAE (CRASSULACEAE)

Uhl , Charles H. (Cornell U., Ithaca, New York.) Chromosomes of the Sempervivoideae (Crassulaceae). Amer. Jour. Bot. 48(2): 114–123. Illus. 1961.—Chromosome numbers are reported for 207 collections representing 68 of the ca. 95 species in this subfamily. Basic numbers are 16, 17, 18, and 19 in Sempervivum, Section Sempervivum (10 species, with many tetraploids and one hexaploid); 19 in Sempervivum, Section Jovisbarba (5 species, all diploid); 15 in Aichryson (9 species, including 1 aneuploid, 1 tetraploid, and 1 aneutetraploid); and strictly 18 in Aeonium (31 species, including 4 wholly and 1 partly tetraploid), Greenovia (3 species, 1 partly tetraploid), and Monanthes (10 species, including 2 wholly and 1 partly tetraploid). The cytological evidence appears decisive in ranking several species of disputed generic position definitely with Aichryson rather than with Aeonium. Possible relationships between various Canarian genera and certain North African species often classed in Sedum are discussed briefly in the light of the scanty morphological and cytological evidence. It is suggested that both these groups may be descended from the same ancestors that were widespread in North Africa before the deserts developed.